Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986337 When Taken by Mouth by Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
- Status
- COMPLETED
- Phase
- N/A
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
ACTIV-2: A Study for Outpatients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Development of ImmunOncoTool
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India
- Status
- COMPLETED
- Phase
- PHASE4
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy
- Status
- COMPLETED
- Phase
- N/A
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants
- Status
- WITHDRAWN
- Phase
- PHASE2
Relative Levels of BMS-986036 in Blood Plasma in Healthy, Overweight, and Obese Participants Following Subcutaneous Administration Via Auto-injector Versus Pre-filled Syringe
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Abatacept for Patients With COVID-19 and Respiratory Distress
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2